MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-09-0001401
Welbeck Pharmaceuticals Private Limited
Welbeck Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹63.48 Lakh
▼ 20% YoY
Net profit · FY 2025
₹43,397
Net margin 0.7%
EBITDA · FY 2025
₹1.12 Lakh
EBITDA margin 1.8%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹26 Lakh
Issued & subscribed
Open charges
₹8.5 Lakh
Secured borrowings
Company age
39 yrs
Est. 1987
Employees · EPFO
2
Provident fund records
About Welbeck Pharmaceuticals Private Limited
Data last updated:
Welbeck Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 September 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1987PTC029176. Its GSTIN is 07AAACW0835A1ZV (Delhi).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹26 Lakh. It is led by directors Veena Anand and Nazir Ahmad Tali.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 27 Amar Colonylajpat Nagar – IV, New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2025, the company reported a revenue of ₹63.48 Lakh, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹43,397 (net margin 0.7%) and EBITDA of ₹1.12 Lakh (EBITDA margin 1.8%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 16% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹8.5 Lakh on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it.
Welbeck Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-09-0001401). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74899DL1987PTC029176
Registration Number 029176
Incorporation Date 10 September 1987
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-09-0001401
Key People
Veena Anand Director Nazir Ahmad Tali Director Recognitions & Rankings of Welbeck Pharmaceuticals
Contact details
Welbeck Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA – 27 Amar Colonylajpat Nagar – IV, New Delhi, Delhi, India – 110024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Welbeck Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Welbeck Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Welbeck Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Welbeck Pharmaceuticals Private Limited, buy the company report.
Financials of Welbeck Pharmaceuticals Private Limited
FY 2025 filings availableWelbeck Pharmaceuticals Private Limited reported revenue of ₹63.48 Lakh (down 20% YoY) for FY 2025.
Revenue · FY 2025
₹63.48 Lakh ▼ 20%
Net profit · FY 2025
₹43,397 margin 0.7%
EBITDA · FY 2025
₹1.12 Lakh margin 1.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 20%
3 years · compounded
▼ 10%
5 years · compounded
▼ 16%
EBITDA CAGR growth
1 year
▼ 62%
3 years · compounded
▲ 27%
5 years · compounded
▼ 39%
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 20% fall in the latest year. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹43,397 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Welbeck Pharmaceuticals Private Limited, buy the company report.
Board of directors of Welbeck Pharmaceuticals Private Limited
Welbeck Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veena Anand | Director | 10 Sep 1987 | 39 Years 2 Months | Current |
| Nazir Ahmad Tali | Director | 10 Sep 1987 | 39 Years 2 Months | Current |
Peer comparison
Welbeck Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gat Pharmaceuticals Private Limited | ₹63.66 Lakh (FY 2022) | 0.0% | Manimajra, Chandigarh, India | |||
| GSM Pharma Private Limited | ₹63.6 Lakh (FY 2025) | -22.0% | Mohali, Punjab, India | |||
| Bionisa Lifesciences Private Limited | ₹63.49 Lakh (FY 2018) | 47.0% | Chennai, Tamil Nadu, India | |||
| Welbeck Pharmaceuticals Private Limitedthis company | ₹63.48 Lakh (FY 2025) | ₹43,397 | 0.7% | -20.0% | 2 | New Delhi, Delhi, India |
| LMGG Pharmaceuticals Private Limited | ₹63.45 Lakh (FY 2025) | 147.0% | Jaipur, Rajasthan, India | |||
| Driven Pharmaceuticals Private Limited | ₹63.45 Lakh (FY 2024) | 48.0% | Lucknow, Uttar Pradesh, India | |||
| Kiaora Pharmaceuticals Private Limited | ₹63.35 Lakh (FY 2025) | -22.0% | Jalandhar, Punjab, India |
To see the full peer comparison of Welbeck Pharmaceuticals Private Limited, buy the company report.
Auditor
Welbeck Pharmaceuticals Private Limited is audited by GHOSH KHANNA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GHOSH KHANNA & CO | FY 2019 | 003366N |
Shareholding
The shareholding of Welbeck Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Welbeck Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Mar 2008 | 10093046 | The Jammu and Kashmir Bank Limited | ₹8.5 Lakh | Open |
To see the full charge records of Welbeck Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Welbeck Pharmaceuticals Private Limited has 5 court cases on record: 2 filed by Welbeck Pharmaceuticals, 3 filed against it. All cases are disposed.
Total cases
5
Filed by the company
2
Filed against the company
3
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 3 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Civil suit | Filed against the company by M/S Jasonkhiya Securities Pvt. Ltd. | Disposed |
| District court, South East, Delhi | Civil suit | Filed against the company by M/S Jasonkhiya Securities Pvt Ltd | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by M/S Pharmaroots Healthcare | Disposed |
| District court, Central, Delhi | Execution petition | Filed by the company against an individual | Disposed |
| District court, Central, Delhi | Civil suit | Filed by the company against individuals | Disposed |
To see the full case history of Welbeck Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Welbeck Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Welbeck Pharmaceuticals Private Limited has a workforce of 2 employees on its EPFO records as of Mar 2023, across 1 active EPFO establishment.
Employee count
2
Active EPFO establishments
1
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2022-23 | 2 |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Welbeck Pharmaceuticals Private Limited, buy the company report.
GST
Welbeck Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACW0835A1ZV | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Welbeck Pharmaceuticals Private Limited, buy the company report.
Recent activity
Welbeck Pharmaceuticals Private Limited has 4 board changes on record since 1987: 3 appointments and 1 cessation. The latest: Ashok Kumar Anand ceased to be Director on 13 Nov 2024.
AGM
Welbeck Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Welbeck Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Ashok Kumar Anand ceased to be Director.
Charges
A charge with The Jammu And Kashmir Bank Limited of Rs. 8.50 Lakh registered on 05 Mar 2008 with Charge ID 10093046 was modified on 24 Apr 2014.
Charges
A charge with The Jammu And Kashmir Bank Limited amounted to Rs. 8.50 Lakh with Charge ID 10093046 was registered on 05 Mar 2008.
Appointed
Ashok Kumar Anand was appointed as Director.
Appointed
Nazir Ahmad Tali was appointed as Director.
Appointed
Veena Anand was appointed as Director.
Incorporation
10 Sep 1987
Welbeck Pharmaceuticals Private Limited was registered on 10 Sep 1987 with Roc Delhi & aged 39 years 2 months as per MCA records.
Frequently asked questions
Welbeck Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 September 1987 (39+ years old) and is registered under CIN U74899DL1987PTC029176.
Welbeck Pharmaceuticals has 2 current directors:
- Veena Anand - Director
- Nazir Ahmad Tali - Director
The latest financial statements of Welbeck Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Welbeck Pharmaceuticals is 07AAACW0835A1ZV, registered in Delhi.
The CIN (Corporate Identification Number) of Welbeck Pharmaceuticals is U74899DL1987PTC029176. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Welbeck Pharmaceuticals has 5 court cases on record: 2 filed by the company and 3 filed against it.
Welbeck Pharmaceuticals was incorporated on 10 September 1987, making it 39+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Welbeck Pharmaceuticals by revenue are Gat Pharmaceuticals Private Limited, GSM Pharma Private Limited, Bionisa Lifesciences Private Limited, LMGG Pharmaceuticals Private Limited, Driven Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ashok Kumar Anand ceased to be Director on 13 Nov 2024. Ashok Kumar Anand was appointed as Director on 01 Feb 1991. Nazir Ahmad Tali was appointed as Director on 10 Sep 1987. Welbeck Pharmaceuticals has 4 board changes on record in total.
Yes, Welbeck Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-09-0001401).
The registered office of Welbeck Pharmaceuticals is at A – 27 Amar Colonylajpat Nagar – IV, New Delhi, Delhi, India – 110024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages